Inotiv, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Health Services » Servicestothe Health Industry
IQVIQVIA Holdings, Inc. -0.62%189.440.0%$163.31m
LHLaboratory Corp. of America Holdings -0.67%211.612.5%$124.08m
DGXQuest Diagnostics, Inc. -0.40%122.354.9%$105.97m
AMEHApollo Medical Holdings, Inc. 1.26%41.090.0%$10.29m
NOTVInotiv, Inc. -2.03%17.640.0%$3.44m
NRCNational Research Corp. 1.27%39.240.0%$1.84m
BASIBioanalytical Systems, Inc. -2.03%17.640.2%$1.82m
WTRHWaitr Holdings, Inc. 3.35%0.170.0%$0.52m
QIPTQuipt Home Medical Corp. -3.68%4.190.0%$0.25m
PMDPsychemedics Corp. -4.46%6.210.7%$0.04m

Company Profile

Inotiv, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The firm operates through the following business segments: Research Services and Research Products. The Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.